Currently, there are limited supplies of the reagents used for HIV-1 Western Blot and HIV-2 EIA testing. In order to conserve the remaining reagent, a controlled process of batch testing was implemented. Therefore, you will likely see additional delays in receiving these supplemental test results.
Read about our plan to mitigate this on the Communications page by clicking this link: Communications
As a friendly reminder, airlines often change their routine flights and cargo hours for holidays. We...
On December 28, 2021, the FDA updated the emergency use authorization (EUA) for COVID-19 conva...
Just a reminder that the revised client forms implement today! Don't forget to toss your o...
As a service to our partners, CTS provides a copy of all licenses and accreditations on our website....
CTS successfully implemented Donor-Screen HLA® Class I and II testing on the Stratec Biomedical ...